Marie Frimodt‐Møller

Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial

Nete Tofte, Morten Lindhardt, Katarina Adamova et al. · The Lancet Diabetes & Endocrinology · 2020 · 254 citations · Full text

Medicine, Endocrinology, Nephrology +17

Effects of Dapagliflozin on Volume Status When Added to Renin–Angiotensin System Inhibitors

Mie K. Eickhoff, Claire C. J. Dekkers, Bart J. Kramers et al. · Journal of Clinical Medicine · 2019 · 93 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Lipidomic analysis reveals sphingomyelin and phosphatidylcholine species associated with renal impairment and all-cause mortality in type 1 diabetes

Nete Tofte, Tommi Suvitaival, Linda Ahonen et al. · Scientific Reports · 2019 · 93 citations · Full text

Medicine, Biochemistry, Nephrology +17

Acute effects of dapagliflozin on renal oxygenation and perfusion in type 1 diabetes with albuminuria: A randomised, double-blind, placebo-controlled crossover trial

Jens Christian Laursen, Niels Søndergaard Heinrich, Joana Mendes Lopes de Melo et al. · EClinicalMedicine · 2021 · 81 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Metabolomic Assessment Reveals Alteration in Polyols and Branched Chain Amino Acids Associated With Present and Future Renal Impairment in a Discovery Cohort of 637 Persons With Type 1 Diabetes

Nete Tofte, Tommi Suvitaival, Kajetan Trôst et al. · Frontiers in Endocrinology · 2019 · 65 citations · Full text

Medicine, Biochemistry, Nephrology +17